Navigation Links
Combination Therapies Continue to Thrive Among Pharma Brands

A new study shows that combination therapies - combining two or more medications into one formulation - continue to be viable, affordable options for pharmaceutical brand teams to pursue and grow product franchise value.

Cutting Edge Information's report "Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies" reveals that 58% of companies that launch combination therapies increase revenues for their brands. The pharmaceutical industry shows no signs of slowing the trend to develop and promote combination drugs with new DTC advertisements for brands such as Vytorin and Caduet being broadcast.

"One reason the companies are pursuing combination therapies so heavily is that they are relatively cheap and a great solution to many generic woes," said Elio Evangelista, research team leader at Cutting Edge Information. Many companies can produce combination therapies for a fraction of the initial costs to develop the ingredient medications. Furthermore, combination drugs can often garner additional patent protection due to the nature of their new chemical makeup.

Research into combination therapies has met with both success and challenges. Pfizer backed off its initial plans to launch a combination of Lipitor with its new compound torcetrapib. However, as recently as March 2007, Roche had found success in combining a new investigational treatment for HIV with two existing treatments, Fuzeon and Prezista. According to a company statement, 98% of patients who received the investigational integrase inhibitor raltegravir, along with Fuzeon and the protease inhibitor Prezista, achieved undetectable levels of HIV according to new interim clinical data.

"Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies" examines combination therapies, along with six other lifecycle management strategies, to understand the mo tivating factors driving relaunch decisions. Furthermore, Cutting Edge Information collected key benchmarks on the strategies' average implementation costs, average return on investment, effectiveness and timing.


'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... ... May kicked off with Melanoma Monday , a multi-agency effort to raise ... encouraging her patients, as well as residents all around Dallas, Cleburne, Irving, and Plano, ... in the future. , The dermatology-specific awareness month ends with “Don’t Fry Day,” established ...
(Date:5/4/2016)... ... May 04, 2016 , ... Momsense, Inc. ... The company’s patented technology, The Smart Breastfeeding Meter, is designed to monitor and ... technology is now available for purchase at Target.com . , Breastfeeding ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of ... life forever with a same-day LASIK procedure at Christenbury Eye Center. The ... Jonathan Christenbury performed her surgery the same day as her in-office consultation and eye ...
(Date:5/4/2016)... ... May 04, 2016 , ... The preeminent surgical aftercare facility Pearl Recovery ... breast cancer surgery. In March 2016, the 61-year-old model and reality TV star was ... occurs in the milk ducts, according to an interview with the Daily Mail ...
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator is the ... In upcoming months, AudioEducator has lined up some informative training session for the ... give complete compliance know-how and practical, easy-to-apply advice. , On Thursday, May 19, ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
(Date:5/3/2016)... 4, 2016 Research and Markets ... Stem Cell Therapy Market Outlook 2020" report to ... ) , ,Recombinant technology has improved significantly in past ... be developed in coming years. Many cancer drugs have ... cell therapies are also expected to be developed with ...
(Date:5/3/2016)... , May 3, 2016  While you may be familiar with watching a film or ... also known as ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a renowned authorized ... innovative technology. Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
Breaking Medicine Technology: